Allarity Therapeutics Inc (ALLR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 12,313 | 3,371 | 4,240 | 4,879 | 4,426 |
| Operating Income | -12,313 | -3,371 | -4,240 | -4,879 | -4,426 |
| Interest Expense | 50 | 426 | 102 | 230 | 34 |
| Other Income | 396 | 2,168 | 495 | 3,470 | 13 |
| Pre-tax Income | -11,967 | -1,629 | -3,847 | -1,639 | -4,447 |
| Income Tax | -377 | N/A | -4 | N/A | N/A |
| Net Income Continuous | -11,590 | -1,629 | -3,843 | -1,722 | -4,447 |
| Net Income | $-11,590 | $-1,629 | $-3,843 | $-1,722 | $-4,447 |
| EPS Basic Total Ops | -7.71 | -3.30 | -664.86 | 201,838.30 | -1,346.09 |
| EPS Basic Continuous Ops | -7.36 | -3.27 | -658.46 | 191,971.00 | -1,078.06 |
| EPS Diluted Total Ops | -7.71 | -3.30 | -664.86 | 201,838.30 | -1,346.09 |
| EPS Diluted Continuous Ops | -7.36 | -3.27 | -658.46 | 191,971.00 | -1,078.06 |
| EPS Diluted Before Non-Recurring Items | N/A | -3.30 | -664.86 | N/A | -1,345.35 |
| EBITDA(a) | $-2,605 | $-3,370 | $-4,238 | $-4,870 | $-4,417 |